Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study.

Cancer research communications·2026
Same author

KMT5C-H4K20me3 drives changes in epigenetic landscape independent of H3K9me3.

bioRxiv : the preprint server for biology·2026
Same author

<i>Streptomyces</i> Autoregulator Biosensors from Natural Product Cluster-Situated Regulators.

ACS chemical biology·2026
Same author

<b>Title:</b> DAP-Seq Reveals Cluster-Situated Regulator Control of Numerous <i>Streptomyces</i> Natural Product Biosynthetic Genes.

Journal of natural products·2026
Same author

Author Correction: Discovery of chirally dependent protein modifications by D- and L-2-hydroxyglutarates.

Nature chemistry·2026
Same author

Investigating Metabolically Altered Pathways in Small Cell Lung Cancer: From RNA Sequencing Analysis to Seahorse-Based Functional Validation.

Methods and protocols·2026
Same journal

ERG orchestrates a dedifferentiation-senescence-inflammation triad in prostate cancer.

Molecular cancer research : MCR·2026
Same journal

Comprehensive multi-omic profiling of desmoplastic small round cell tumors identifies targetable pathways with therapeutic opportunities.

Molecular cancer research : MCR·2026
Same journal

CELF2 is a tumor suppressor that modulates SLC7A11 and promotes ferroptosis in stomach adenocarcinoma.

Molecular cancer research : MCR·2026
Same journal

MYC-Mediated USP39 Upregulation Stabilizes SRSF1 in Pancreatic Cancer.

Molecular cancer research : MCR·2026
Same journal

Ceramide-induced endoplasmic reticulum stress reveals a targetable vulnerability in endocrine therapy-resistant breast cancer.

Molecular cancer research : MCR·2026
Same journal

Mapping the Subtype-Specific PARP1 ADP-ribosylated Proteome in Breast Cancer Cells.

Molecular cancer research : MCR·2026
See all related articles

Related Experiment Video

Updated: Jun 25, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.4K

miR-497 Target Gene Regulatory Network in Angiosarcoma.

Annaleigh Benton1,2, Noah M Moriarty2,3, Emma Terwilliger1,2

  • 1Department of Biological Sciences, Purdue University, West Lafayette, Indiana.

Molecular Cancer Research : MCR
|May 21, 2024
PubMed
Summary
This summary is machine-generated.

MicroRNA-497-5p (miR-497) shows potent tumor-suppressive effects in aggressive angiosarcoma. Overexpression of miR-497 inhibits cell viability, migration, and tumor formation, suggesting its therapeutic potential.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.6K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.6K

Related Experiment Videos

Last Updated: Jun 25, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.4K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.6K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.6K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Angiosarcoma is an aggressive vascular cancer with limited treatment options.
  • DICER1, crucial for microRNA (miRNA) biogenesis, is implicated in angiosarcoma development.
  • Identifying novel therapeutic targets is critical for improving patient outcomes.

Purpose of the Study:

  • To investigate the tumor-suppressive role of microRNA-497-5p (miR-497) in angiosarcoma.
  • To elucidate the molecular mechanisms underlying miR-497's function in angiosarcoma.
  • To identify potential therapeutic vulnerabilities in angiosarcoma.

Main Methods:

  • Screening of tumor-suppressive miRNAs in angiosarcoma cell lines.
  • Overexpression of miR-497 and assessment of cell viability, migration, and tumor formation.
  • RNA-sequencing, patient data analysis, and target prediction to identify miR-497 targets.
  • Validation of direct regulation of target genes, including VAT1.

Main Results:

  • miR-497 significantly suppressed angiosarcoma cell viability, migration, and tumor formation.
  • miR-497 directly regulates key genes: cyclin-D2, cyclin-dependent kinase 6, and vesicle amine transport protein 1 (VAT1).
  • Pharmacologic inhibition of VAT1 with neocarzilin A reduced angiosarcoma cell migration.

Conclusions:

  • miR-497 exhibits significant tumor-suppressive properties in angiosarcoma.
  • miR-497's therapeutic potential warrants further investigation for angiosarcoma treatment.
  • Understanding miR-497's regulatory network provides insights into angiosarcoma pathogenesis and potential therapeutic strategies.